vaccinated in route
immunizes host
Homo sapiens
intranasal route
AdCOVID
vaccine
Philip Huang
A SARS-CoV-2 single dose intranasal vaccine manufactured by Altimmune in collaboration with the University of Alabama-Birmingham. This vaccine was discontinued after a Phase 1 trial.
https://altimmune.com/adcovid/
COVID-19 recombinant adenoviral vector vaccine